Mangalam Drugs

{
  "main_header": {
    "sid": 138636,
    "name": "Mangalam Drugs",
    "stock_name": "Mangalam Drugs",
    "full_name": "Mangalam Drugs and Organics Ltd",
    "name_url": "stocks-analysis/mangalam-drugs",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "36.01",
    "chg": -1.89,
    "chgp": "-4.99%",
    "dir": -1,
    "prev_price": "37.90",
    "mcapval": "57.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532637,
    "symbol": "MANGALAM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE584F01014",
    "curr_date": "Feb 04",
    "curr_time": "",
    "bse_nse_vol": "2.2 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 04, 2026",
    "traded_date_str": "2026 02 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mangalam-drugs-138636-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3820114",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MangalamDrugsan_stocks_hitting_lower_circuit_3820114.png",
        "date": "2026-02-04 10:00:10",
        "description": "Shares of Mangalam Drugs and Organics Ltd plunged to their lower circuit limit on 4 February 2026, closing at ₹36.01, down 4.99% on the day. The stock faced intense selling pressure, with volumes surging and the price hitting the maximum permissible daily loss, reflecting mounting investor concerns amid a deteriorating outlook."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Robust Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-robust-buying-pressure-3818011",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MangalamDrugsan_stocks_hitting_upper_circuit_3818011.png",
        "date": "2026-02-03 10:00:24",
        "description": "Mangalam Drugs and Organics Ltd surged to its upper circuit limit on 3 February 2026, propelled by robust buying interest and significant investor participation. The stock closed at ₹37.90, marking a 4.99% gain on the day, outperforming its sector and the broader market indices."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3816005",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MangalamDrugsan_stocks_hitting_lower_circuit_3816005.png",
        "date": "2026-02-02 10:00:06",
        "description": "Mangalam Drugs and Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 2 Feb 2026, hitting its lower circuit price limit of ₹32.68. The stock endured intense selling pressure, culminating in a maximum daily loss of 4.97%, marking its ninth consecutive day of decline and signalling mounting investor panic amid deteriorating fundamentals."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3814370",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MangalamDrugsan_stocks_hitting_lower_circuit_3814370.png",
        "date": "2026-02-01 11:00:08",
        "description": "Mangalam Drugs and Organics Ltd witnessed a sharp decline on 1 Feb 2026, hitting its lower circuit limit of 5%, closing at ₹34.39. The stock faced intense selling pressure, marking its eighth consecutive day of losses and underperforming the Pharmaceuticals & Biotechnology sector by over 5% today."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3810870",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MangalamDrugsan_stocks_hitting_lower_circuit_3810870.png",
        "date": "2026-01-30 10:00:09",
        "description": "Mangalam Drugs and Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 30 Jan 2026, hitting its lower circuit price limit of ₹36.20. The stock endured intense selling pressure, closing with a maximum daily loss of 4.99%, marking its seventh consecutive day of decline and signalling heightened investor anxiety."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3809092",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MangalamDrugsan_stocks_hitting_lower_circuit_3809092.png",
        "date": "2026-01-29 10:00:10",
        "description": "Mangalam Drugs and Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 29 Jan 2026, hitting its lower circuit price limit of ₹38.10. The stock suffered a maximum daily loss of 4.99%, reflecting intense selling pressure and panic among investors amid deteriorating market sentiment and weak trading volumes."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3807243",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MangalamDrugsan_stocks_hitting_lower_circuit_3807243.png",
        "date": "2026-01-28 10:00:07",
        "description": "Mangalam Drugs and Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 28 Jan 2026, hitting its lower circuit price limit of ₹40.1. The stock endured intense selling pressure, closing with a maximum daily loss of 5.0%, reflecting mounting investor concerns and a continuation of a bearish trend that has seen the share price fall by over 22% in the past five trading sessions."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3805504",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MangalamDrugsan_stocks_hitting_lower_circuit_3805504.png",
        "date": "2026-01-27 10:00:09",
        "description": "Mangalam Drugs and Organics Ltd witnessed intense selling pressure on 27 Jan 2026, triggering the stock to hit its lower circuit limit of 5%, closing at ₹42.21. This marks the fourth consecutive day of decline, with the stock shedding 18.53% over this period, signalling heightened investor anxiety and a sharp loss of confidence in the micro-cap pharmaceutical player."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Falls 5.46%: 5 Key Factors Behind the Volatile Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-falls-546-5-key-factors-behind-the-volatile-week-3804302",
        "imagepath": "",
        "date": "2026-01-25 16:00:11",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>19 Jan:</strong> New 52-week high and upper circuit hit at Rs.49.45 (+4.99%)</p>\n                    <p><strong>20 Jan:</strong> Upper circuit hit again at Rs.51.92 (+4.99%)</p>\n                    <p><strong>21 Jan:</strong> Third consecutive upper circuit at Rs.54.40 (+5.00%)</p>\n                    <p><strong>22 Jan:</strong> Lower circuit hit amid heavy selling at Rs.46.87 (-4.99%)</p>\n                    <p><strong>23 Jan:</strong> Locked lower circuit at Rs.44.53 (-4.99%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.47.10</div></div>\n           ..."
      }
    ],
    "total": 167,
    "sid": "138636",
    "stock_news_url": "https://www.marketsmojo.com/news/mangalam-drugs-and-organics-138636"
  },
  "announcements": [
    {
      "details": "Mangalam Drugs And Organics Limitedalam Drugs And Organics Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Mangalam Drugs And Organics Limited - Reply to Clarification- Financial results",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Mangalam Drugs And Organics Limitedgs And Organics Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Mangalam Drugs And Organics Limited - Clarification - Financial Results",
      "datetime": "21-Nov-2019"
    },
    {
      "details": "Mangalam Drugs And Organics Limited has informed the Exchange regarding Compliance under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Mangalam Drugs And Organics Limited - Other General Purpose",
      "datetime": "15-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mangalam Drugs and Organics Ltd has declared <strong>5%</strong> dividend, ex-date: 21 Dec 17",
          "dt": "2017-12-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure

2026-02-04 10:00:10

Shares of Mangalam Drugs and Organics Ltd plunged to their lower circuit limit on 4 February 2026, closing at ₹36.01, down 4.99% on the day. The stock faced intense selling pressure, with volumes surging and the price hitting the maximum permissible daily loss, reflecting mounting investor concerns amid a deteriorating outlook.

Read full news article

Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Robust Buying Pressure

2026-02-03 10:00:24

Mangalam Drugs and Organics Ltd surged to its upper circuit limit on 3 February 2026, propelled by robust buying interest and significant investor participation. The stock closed at ₹37.90, marking a 4.99% gain on the day, outperforming its sector and the broader market indices.

Read full news article

Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure

2026-02-02 10:00:06

Mangalam Drugs and Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 2 Feb 2026, hitting its lower circuit price limit of ₹32.68. The stock endured intense selling pressure, culminating in a maximum daily loss of 4.97%, marking its ninth consecutive day of decline and signalling mounting investor panic amid deteriorating fundamentals.

Read full news article

Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure

2026-02-01 11:00:08

Mangalam Drugs and Organics Ltd witnessed a sharp decline on 1 Feb 2026, hitting its lower circuit limit of 5%, closing at ₹34.39. The stock faced intense selling pressure, marking its eighth consecutive day of losses and underperforming the Pharmaceuticals & Biotechnology sector by over 5% today.

Read full news article

Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure

2026-01-30 10:00:09

Mangalam Drugs and Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 30 Jan 2026, hitting its lower circuit price limit of ₹36.20. The stock endured intense selling pressure, closing with a maximum daily loss of 4.99%, marking its seventh consecutive day of decline and signalling heightened investor anxiety.

Read full news article

Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure

2026-01-29 10:00:10

Mangalam Drugs and Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 29 Jan 2026, hitting its lower circuit price limit of ₹38.10. The stock suffered a maximum daily loss of 4.99%, reflecting intense selling pressure and panic among investors amid deteriorating market sentiment and weak trading volumes.

Read full news article

Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure

2026-01-28 10:00:07

Mangalam Drugs and Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 28 Jan 2026, hitting its lower circuit price limit of ₹40.1. The stock endured intense selling pressure, closing with a maximum daily loss of 5.0%, reflecting mounting investor concerns and a continuation of a bearish trend that has seen the share price fall by over 22% in the past five trading sessions.

Read full news article

Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure

2026-01-27 10:00:09

Mangalam Drugs and Organics Ltd witnessed intense selling pressure on 27 Jan 2026, triggering the stock to hit its lower circuit limit of 5%, closing at ₹42.21. This marks the fourth consecutive day of decline, with the stock shedding 18.53% over this period, signalling heightened investor anxiety and a sharp loss of confidence in the micro-cap pharmaceutical player.

Read full news article

Mangalam Drugs and Organics Ltd Falls 5.46%: 5 Key Factors Behind the Volatile Week

2026-01-25 16:00:11

Key Events This Week

19 Jan: New 52-week high and upper circuit hit at Rs.49.45 (+4.99%)

20 Jan: Upper circuit hit again at Rs.51.92 (+4.99%)

21 Jan: Third consecutive upper circuit at Rs.54.40 (+5.00%)

22 Jan: Lower circuit hit amid heavy selling at Rs.46.87 (-4.99%)

23 Jan: Locked lower circuit at Rs.44.53 (-4.99%)

Week Open

Rs.47.10

...

Read full news article

View All News